IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Immunocellular Therapeutics

CUSIP: 452536113 | 3 institutional holders

Quarters

Q3 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Sabby Management, LLC15,161,641
0.0% of portfolio›$1.1K
Anson Funds Management LPA4,687,500
0.1% of portfolio›$553
UBS Group AG41,100
0.0% of portfolio›$2
StyleTurnoverLocationFiled
Sabby Management, LLC
15,161,641$1.1K0.0%GrowthVery HighMiami Beach, FL2016-11-14
Anson Funds Management LPActivist
4,687,500$5530.1%GARPVery HighDallas, TX2016-11-23
UBS Group AG
41,100$20.0%CoreMediumZurich, Switzerland2016-11-14